La Celle Saint Cloud, France

Pierre Lestage

USPTO Granted Patents = 42 

 

Average Co-Inventor Count = 4.4

ph-index = 7

Forward Citations = 130(Granted Patents)


Location History:

  • Paris, FR (1991 - 1997)
  • La Celle Saint Cloud, FR (1998 - 2009)
  • Le Celle St Cloud, FR (2010)
  • La Celle St Cloud, FR (2001 - 2011)
  • Le Celle Saing Cloud, FR (2012)
  • Le Celle Saint Cloud, FR (2011 - 2013)

Company Filing History:


Years Active: 1991-2013

Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents

Title: Pierre Lestage: Innovator Extraordinaire in Medicinal Chemistry

Introduction:

Meet Pierre Lestage, a brilliant innovator and expert in the field of medicinal chemistry hailing from La Celle Saint Cloud, France. With an impressive portfolio of 42 patents, Pierre has made significant contributions to the field through his groundbreaking inventions and pharmaceutical compositions. In this article, we delve into his latest patents, career highlights, collaborations, and applaud his remarkable contributions to scientific advancements.

Latest Patents:

Pierre Lestage's latest patents showcase his expertise in developing compounds and pharmaceutical compositions that target the AMPA receptor, a key player in various physiological and pathological processes. One of his recent patents includes the invention of dihydrobenzoxathiazepine compounds (Formula I) that serve as modulators of the AMPA receptor. These compounds have immense potential in the development of medicinal products for treating conditions associated with AMPA receptor modulation.

In addition to dihydrobenzoxathiazepine compounds, Pierre Lestage has also patented benzothiadiazepine compounds (Formula I). These compounds act as AMPA receptor modulators and NMDA receptor antagonists, thereby aiding in the treatment and prevention of conditions treatable by such receptor modulation.

Career Highlights:

Pierre Lestage has an illustrious career and has been associated with renowned companies in the pharmaceutical industry. Notably, he has worked with Les Laboratoires Servier and Adir et Compagnie. With his significant contributions, Pierre has undoubtedly played a pivotal role in driving scientific innovation within these organizations.

Collaborations:

Pierre Lestage has had the privilege of collaborating with esteemed professionals in his field, such as Patrice Desos and Alex Cordi. These collaborations have undoubtedly contributed to the success and advancement of his research and patent endeavors. Through these partnerships, Pierre has had the opportunity to exchange ideas, share expertise, and collectively push the boundaries of medicinal chemistry.

Conclusion:

Pierre Lestage's remarkable journey as an innovator and inventor in medicinal chemistry has left an indelible mark on scientific advancements. With 42 patents under his belt, including his groundbreaking inventions of compounds targeting the AMPA receptor, Pierre continues to make valuable contributions to the field.

We commend Pierre Lestage for his dedication, expertise, and his ability to drive innovation in the development of pharmaceutical compositions. His work not only showcases his brilliance as an inventor but also contributes significantly to the advancement of healthcare and the betterment of human lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…